Johnson Johnson Will Pay $300M To Women Who’ve Suffered From Pelvic Mesh Implant Complications The settlement will help cover women's ongoing treatment for injuries caused by the mesh implants. Pedestrian.tv · Sep 12, 2022
Pelvic mesh class actions settle for $300m Two class actions against Johnson & Johnson over defective pelvic mesh products have settled for $300 million, finalising almost 10 years of legal fighting. AAP · Sep 12, 2022
Johnson & Johnson reaches $300m settlement over pelvic mesh implants Settlement of two Australian class actions is largest in country’s history and subject to federal court approval The Guardian - AU · Sep 12, 2022
Johnson & Johnson Whale Trades Spotted Someone with a lot of money to spend has taken a bearish stance on Johnson & Johnson (NYSE:JNJ). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Benzinga · Aug 31, 2022
This Is What Whales Are Betting On Johnson & Johnson Someone with a lot of money to spend has taken a bullish stance on Johnson & Johnson (NYSE:JNJ). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Benzinga · Aug 29, 2022
Johnson & Johnson Whale Trades For August 23 Someone with a lot of money to spend has taken a bullish stance on Johnson & Johnson (NYSE:JNJ). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Benzinga · Aug 23, 2022
Pharma funds Illinois pols, ‘Sister Jean’ turns 103, Honest Chicagoans talk Air and Water Show and more in your Chicago news roundup Today’s update is a 5-minute read that will brief you on the day’s biggest stories. Chicago Sun-Times · Aug 19, 2022
Illinois Senate President Don Harmon, other pols keep taking money from pharma companies implicated in opioid crisis The Oak Park Democrat continues to accept campaign money from Johnson & Johnson, 1 of 4 companies paying $26 billion to settle suits accusing them of fueling the crisis. He’s not the only Illinois official doing so. Chicago Sun-Times · Aug 19, 2022
If You Invested $1,000 In Johnson & Johnson Stock At Its COVID-19 Pandemic Low, Here's How Much You'd Have Now Investors who bought stocks during the COVID-19 market crash in 2020 have generally experienced some big gains in the past two years. But there is no question some big-name stocks performed better than others since the pandemic bottom. Benzinga · Aug 17, 2022
Johnson & Johnson baby powder to be removed from all UK stores in 2023 The company cites commercial reasons and has blamed 'misinformation' over the safety of the product for its declining sales in the past. Daily Record · Aug 13, 2022
More than a half billion doses of COVID vaccine made in Baltimore dumped, congressional panel finds BALTIMORE — The tally of wasted COVID-19 vaccine continues to climb at the troubled Emergent BioSolutions plant in East Baltimore and now exceeds a half billion doses, according to findings a congressional panel released Thursday on the manufacturer once central to the U.S. coronavirus pandemic response. Tribune News Service · Aug 11, 2022
Walgreens fueled San Francisco's opioid crisis with thousands of 'suspicious orders,' judge rules Walgreens helped fuel the opioid epidemic in San Francisco by shipping hundreds of thousands of "suspicious orders" of prescription drugs to its pharmacies, a federal judge ruled Wednesday. Los Angeles Times · Aug 10, 2022
Johnson & Johnson Whale Trades Spotted Someone with a lot of money to spend has taken a bearish stance on Johnson & Johnson (NYSE:JNJ). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Benzinga · Aug 4, 2022
New book chronicles how America's opioid industry operated like a drug cartel Two Washington Post journalists say pharmaceutical companies collaborated with each other — and with lawyers and lobbyists — to create laws to protect the industry. Their new book is American Cartel. WEKU · Aug 2, 2022
Benzinga · Jul 25, 2022 Johnson & Johnson Whale Trades For July 25 Someone with a lot of money to spend has taken a bullish stance on Johnson & Johnson (NYSE:JNJ). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.
Benzinga · Jul 21, 2022 Things Looking Up at Johnson & Johnson? Johnson & Johnson (NYSE: JNJ) released their financial report for the second quarter of 2022, this week, demonstrating strong growth and promising guidance for the rest of the year. Analysts seem to agree, as the consensus rating for JNJ is MODERATE BUY.
The Independent UK · Jul 18, 2022 Covid vaccine protection ‘short lived,’ booster doses essential, study confirms ‘Continual updating of our vaccinations and booster shots is critical,’ scientists say
Benzinga · Jul 15, 2022 Looking At Johnson & Johnson's Recent Whale Trades Someone with a lot of money to spend has taken a bullish stance on Johnson & Johnson (NYSE:JNJ). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.
Benzinga · Jul 13, 2022 Looking At Johnson & Johnson's Recent Whale Trades Someone with a lot of money to spend has taken a bullish stance on Johnson & Johnson (NYSE:JNJ). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.
The Conversation · Jul 11, 2022 COVID vaccines and pregnancy: a review of the evidence shows they are safe COVID vaccines have been contentious ever since they were developed in response to the coronavirus pandemic, though the evidence is that they are safe and effective. One of the concerns has been whether the vaccines were safe for pregnant women. A recent review looked at the evidence available from North…
Benzinga · Jul 8, 2022 Check Out What Whales Are Doing With JNJ A whale with a lot of money to spend has taken a noticeably bearish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson (NYSE:JNJ) we detected 15 strange trades.
Tribune News Service · Jul 6, 2022 How a Texas town is making itself into an epicenter of the US semiconductor universe In downtown Sherman, Texas, markers explain the city’s past and restaurants and coffee shops boast about the historic buildings they call home.
Benzinga · Jun 30, 2022 Here's How Much You Would Have Made Owning Johnson & Johnson Stock In The Last 15 Years Johnson & Johnson (NYSE:JNJ) has outperformed the market over the past 15 years by 1.01% on an annualized basis producing an average annual return of 7.22%. Currently, Johnson & Johnson has a market capitalization of $465.27 billion.
Benzinga · Jun 28, 2022 What Are Whales Doing With Johnson & Johnson A whale with a lot of money to spend has taken a noticeably bearish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson (NYSE:JNJ) we detected 12 strange trades.